Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.80p
   
  • Change Today:
      0.050p
  • 52 Week High: 14.18
  • 52 Week Low: 5.59
  • Currency: UK Pounds
  • Shares Issued: 713.04m
  • Volume: 601,442
  • Market Cap: £48.49m

Latest ShareCast News

Shield's Canadian partner files new drug submission for Accrufer

By Josh White

Date: Monday 21 Mar 2022

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that KYE Pharmaceuticals has submitted a new drug submission to Health Canada, for the regulatory review and approval of the iron therapy 'Accrufer'.

Shield Therapeutics revenue falls in line with expectations

By Josh White

Date: Thursday 17 Feb 2022

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported total 2021 revenue of £1.5m in a trading update on Thursday, in line with market expectations.

Shield Therapeutics enters Accrufer licensing deal in Canada

By Josh White

Date: Wednesday 05 Jan 2022

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Wednesday, with KYE Pharmaceuticals in Canada.

Shield shares surge on expansion of US coverage ... 16-Dec-2021 ShareCast
Shield Therapeutics appoints chief medical officer 27-Sep-2021 ShareCast
Shield Therapeutics swings to losses in first half 17-Aug-2021 ShareCast
Shield Therapeutics inks exclusive licence for '... 12-Aug-2021 ShareCast
Shield Therapeutics appoints industry veteran Gr... 28-May-2021 ShareCast
Shield taps Hans-Peter Rudolf as its new finance... 22-Mar-2021 ShareCast
Shield's Feraccru gets registration in Australia 09-Mar-2021 ShareCast
Shield Therapeutics FY trading in line with mark... 15-Jan-2021 ShareCast
Shield shares rise as Teva withdraws patent oppo... 19-Oct-2020 ShareCast
Shield Therapeutics shares rise on two recent re... 03-Jun-2020 ShareCast
Shield Therapeutics names Hans Peter Hasler as n... 26-May-2020 ShareCast
Shield Therapeutics FY revenues impacted by mile... 01-May-2020 ShareCast
Shield launches review after spotting flaw in 'F... 17-Mar-2020 ShareCast
Shield Therapeutics details year of 'material pr... 27-Jan-2020 ShareCast
Shield Therapeutics narrows loss as it pursues f... 07-Aug-2019 ShareCast
Shield Therapeutics shares leap as FDA approves ... 26-Jul-2019 ShareCast
Shield Therapeutics narrows losses as it advance... 03-Apr-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 6.80p
Change Today 0.050p
% Change 0.74 %
52 Week High 14.18
52 Week Low 5.59
Volume 601,442
Shares Issued 713.04m
Market Cap £48.49m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.09% below the market average54.09% below the market average54.09% below the market average54.09% below the market average54.09% below the market average
3.33% above the sector average3.33% above the sector average3.33% above the sector average3.33% above the sector average3.33% above the sector average
Price Trend
69.92% below the market average69.92% below the market average69.92% below the market average69.92% below the market average69.92% below the market average
44.26% below the sector average44.26% below the sector average44.26% below the sector average44.26% below the sector average44.26% below the sector average
Income Not Available
Growth
59.51% above the market average59.51% above the market average59.51% above the market average59.51% above the market average59.51% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average

STX Dividends

No dividends found

Trades for 07-Jun-2023

Time Volume / Share Price
12:27 1,020 @ 6.62p
12:12 621 @ 6.62p
12:08 68,875 @ 6.67p
11:47 25,000 @ 6.62p
11:38 14,927 @ 6.62p

Top of Page